Most of these specific mutations (n = 20; 80%) were exclusive to NAT, including those affecting key genes such as NOTCH1 (the most mutated gene), FAT1, or PPARD; while 20% were shared between NAT and tumor tissue, affecting genes such as CDKN2A. This evidence concerns the gene BRD2 and neoplasm.